Description
EMERGENCY PATIENT DRUGS
First action · last action
2012-09-13 · 2012-11-29
Transactions
2
First transaction's obligation
$20,697
Base + all options value (sum of deltas)
$20,671
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-09-13+$20,697= $20,697
- Mod P000012012-11-29-$26= $20,671
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-09-13 | +$20,697 | $20,697 | EMERGENCY PATIENT DRUGS |
| Mod P00001· FUNDING ONLY ACTION | 2012-11-29 | −$26 | $20,671 | EMERGENCY PATIENT DRUGS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UMMFCJWKFE67)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77024P0314 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $235,248 | FY2024 |
| 36C77023P0325 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $235,872 | FY2023 |
| 36C77023P0318 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $223,230 | FY2023 |
| 36C77020P0824 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $4,704 | FY2020 |
| 36C77020P0777 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $21,096 | FY2020 |
| 36F79720D0139 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2020 |
Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24616J4018 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $28,335 | FY2016 |
| VA24616F4029 | ACTELION PHARMACEUTICALS US, INC. | 246-NETWORK CONTRACTING OFFICE 6 | $4,874 | FY2016 |
| VA24616J0011 | GLAXOSMITHKLINE, LLC | 246-NETWORK CONTRACTING OFFICE 6 | $6,390 | FY2016 |
| VA24616J3895 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $8,501 | FY2016 |
| VA24616J3970 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $141,675 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24612P5681_3600_-NONE-_-NONE- · retrieved 2026-09-26.